Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Ways to maintain budget motivation during adjustments helps you stay committed as you recalibrate. Discover practical tips and stay on course.
21,453 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Three well-known retailers face rising pressure as consumer spending cools and online competition intensifies. These ...
Cameco stock sliding below $120 has investors weighing risk and opportunity. This guide breaks down the uranium outlo...
Stock splits often signal strong momentum. Here are three stock-split stocks before they soar, with practical analysi...
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
A noted market analyst warns that Strategy’s aggressive Bitcoin purchases echo dot-com-era speculation, risking a ste...
Microsoft sits near a long-running price anchor as investors weigh AI incentives against macro risks. A decisive move...
When a CEO puts real money behind his own company’s stock, investors sit up and take notice. This article breaks down...
Kalshi has closed two insider trading investigations tied to a former California gubernatorial candidate and a mrbeas...
Vitalik Buterin has surpassed his 16,384 ETH selling target, lifting total disposals beyond 18,000 ETH and valued at ...
Bitcoin sits around $66,800 as the BITO ETF regains attention amid competition from cheaper spot BTC products. Invest...
Carl Icahn’s latest stake move in Icahn Enterprises drew attention from investors. This article breaks down what icah...